Brief: Invivo Says 75% Target Enrollment Achieved For Inspire 2.0 Spinal Cord Injury Study
Sept 8 (Reuters) - InVivo Therapeutics Holdings Corp
NVIV.O :
* INVIVO THERAPEUTICS HOLDINGS CORP - 75% TARGET ENROLLMENT
ACHIEVED FOR INSPIRE 2.0 SPINAL CORD INJURY STUDY
Source text for Eikon: ID:nBw57xpha
Further company coverage: NVIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR